Verdélite Sciences, Emerald Health Therapeutics’ wholly-owned subsidiary, Launches Souvenir™ Cannabis Brand in Québec
23 juin 2020 06h02 HE
|
Verdélite Sciences Inc.
SAINT-EUSTACHE, Quebec, June 23, 2020 (GLOBE NEWSWIRE) -- Verdélite Sciences (“Verdélite”) introduced its new Souvenir Cannabis brand to the Québec adult-use recreational cannabis market on June...
WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
22 juin 2020 08h30 HE
|
WeedMD Rx Inc.
Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolioAdult-use brand “Color Cannabis” vaporizers slated for release in third...
Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
19 juin 2020 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, June 19, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31,...
WeedMD Launches Same-Day Medical Cannabis Delivery Service
18 juin 2020 07h30 HE
|
WeedMD Rx Inc.
TORONTO, June 18, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...
WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries
12 juin 2020 08h34 HE
|
WeedMD Rx Inc.
TORONTO, June 12, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis,...
WeedMD Reports Fiscal Year 2019 Financial Results and First Quarter 2020 Preliminary Revenue of $12 Million
10 juin 2020 23h38 HE
|
WeedMD Rx Inc.
Net revenue of $20.8 million for 2019, up 162% from 2018, and Q4 revenue of $2.9 million, representing a 38% quarterly increase in Adult-Use and Medical sales Harvested 17,988 kgs in 2019, a 921%...
WeedMD to File First Quarter 2020 Financials on or Before July 15
28 mai 2020 08h30 HE
|
WeedMD Rx Inc.
TORONTO, May 28, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis,...
Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results
15 mai 2020 07h00 HE
|
Emerald Health Therapeutics Inc.
Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in...
Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update
14 mai 2020 07h00 HE
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and year ended...
WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020
23 avr. 2020 08h46 HE
|
WeedMD Rx Inc.
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis,...